Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors

CONCLUSIONSThe present study suggests that neithera priori dose individualization nor dose adaptation using TDM is required validating body surface area dosing of etoposide in the TI-CE protocol.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research